Acute myeloid leukemia (AML) presents with symptoms related to pancytopenia (weakness, infections, bleeding diathesis) and organ infiltration with leukemic cells. Galactorrhea is an uncommon manifestation of AML. We report a case of AML presenting with galactorrhea. G alactorrhea can result from excess prolactin secretion secondary to interference of the hypothalamic pituitary axis by neurologic disorders, neoplastic processes, medications, hypothyroidism, and chest wall irritation. Pituitary prolactinoma is the most common cause of galactorrhea, while nonpituitary malignancies such as bronchogenic carcinoma, Hodgkin's lymphoma, and T-cell lymphomas have also been implicated. Infi ltrative disorders and craniopharyngioma inhibit dopamine and induce galactorrhea. Galactorrhea is an uncommon presenting feature of acute myeloid leukemia (AML). To our knowledge, there have been only two prior reports of galactorrhea in patients with AML ( 1, 2 ).
G alactorrhea can result from excess prolactin secretion secondary to interference of the hypothalamic pituitary axis by neurologic disorders, neoplastic processes, medications, hypothyroidism, and chest wall irritation. Pituitary prolactinoma is the most common cause of galactorrhea, while nonpituitary malignancies such as bronchogenic carcinoma, Hodgkin's lymphoma, and T-cell lymphomas have also been implicated. Infi ltrative disorders and craniopharyngioma inhibit dopamine and induce galactorrhea. Galactorrhea is an uncommon presenting feature of acute myeloid leukemia (AML). To our knowledge, there have been only two prior reports of galactorrhea in patients with AML ( 1, 2 ).
CASE HISTORY
A 36-year-old-woman presented with a 2-week history of galactorrhea. She was otherwise asymptomatic and was not on any medications. Her serum prolactin level was 598 ng/mL (reference range, 0-25). Peripheral blood showed 35% atypical cells, which were peroxidase positive. A bone marrow evaluation confi rmed the diagnosis of AML-M4 subtype. Results of magnetic resonance imaging of the brain and analysis of cerebrospinal fl uid were within normal limits. After receiving standard induction chemotherapy with cytarabine and daunorubicin, her galactorrhea and serum prolactin levels normalized within 2 weeks (19 ng/mL). A bone marrow examination confi rmed remission, and she subsequently received consolidation with three cycles of high-dose cytarabine. She has been asymptomatic for the past 4 years of follow up.
DISCUSSION
Symptomatic galactorrhea as the presenting feature of AML-M5 has been documented by Ales et al ( 1 ) and Muslahi et al ( 2 ) . In both cases, the blasts had monocytic diff erentiation, and serum prolactin levels normalized after the patient Acute myeloid leukemia presenting as galactorrhea K. Rakul Nambiar , MD , Sreejith G. Nair , DM , and R. Nandini Devi , MD attained remission. Since AML with monocytic diff erentiation has a high propensity to infi ltrate normal tissues, and prolactin levels normalized after remission, we feel that leukemic blasts were the source of exogenous prolactin. Th is hypothesis has been substantiated by the documentation of bioactive prolactin in the cytoplasm of leukemic cells by immunological methods and the expression of prolactin mRNA in leukemic cell lines ( 3 ) . Lymphoid cells produce prolactin ( 4 ), and stromal cells have basal levels of prolactin synthesis, which can be increased in response to cytokines ( 5 ) . Th ese fi ndings suggest an up-regulation of prolactin secretion as a result of interaction between the myeloid blasts and normal marrow cells. Th is hypothesis could account for the observation of hyperprolactinemia in a wide variety of AML subtypes ( 6 ) . Symptomatic hyperprolactinemia is a rare complication of AML, which may occur in cases with monocytic diff erentiation. Th e relation between prolactin synthesis and hematopoiesis in AML remains unclear.
